Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros




Base de datos
Intervalo de año de publicación
1.
Biol Pharm Bull ; 44(10): 1413-1418, 2021.
Artículo en Inglés | MEDLINE | ID: mdl-34602550

RESUMEN

The triplet antiemetic regimen is administered to prevent chemotherapy-induced nausea and vomiting (CINV) after moderately emetogenic chemotherapy (MEC). However, the superiority of palonosetron over first-generation 5-hydroxytryptamine-3 receptor antagonists in triplet antiemetic therapy remains unclear. In this study, we evaluated the efficacy of palonosetron (PALO) and granisetron (GRA) in triplet antiemetic therapy for CINV. This study included 267 patients who received MEC at our hospital between April 2017 and September 2020. Patients were pretreated with antiemetic therapy comprising PALO or GRA and dexamethasone on day 1 and aprepitant on days 1-3. We evaluated the rate of complete response (CR) (i.e., no vomiting and no use of rescue medication) in the acute phase (0-24 h), delayed phase (24-120 h), and overall phase (0-120 h) after first-cycle chemotherapy. Furthermore, multivariate analysis was conducted to identify risk factors for non-CR. The rate of CR in the overall and delayed phases was significantly higher in the PALO group (91.9 and 91.9%, respectively) than in the GRA group (74.1 and 75.5%, respectively). In the acute phase, the incidence was not different between the GRA and PALO groups (96.5 and 99.2%, respectively). Multivariate analysis revealed that female sex and the use of GRA were risk factors for non-CR. Subgroup analysis revealed the superiority of PALO over GRA in female patients, but not in male patients. In conclusion, PALO was more effective than GRA in triplet antiemetic therapy in preventing CINV during MEC, especially for female patients.


Asunto(s)
Antieméticos/administración & dosificación , Antineoplásicos/efectos adversos , Náusea/epidemiología , Neoplasias/tratamiento farmacológico , Vómitos/epidemiología , Anciano , Aprepitant/administración & dosificación , Quimioterapia Combinada/métodos , Femenino , Granisetrón/administración & dosificación , Humanos , Incidencia , Masculino , Persona de Mediana Edad , Náusea/inducido químicamente , Náusea/prevención & control , Palonosetrón/administración & dosificación , Estudios Retrospectivos , Resultado del Tratamiento , Vómitos/inducido químicamente , Vómitos/prevención & control
2.
Int J Biol Macromol ; 47(2): 201-6, 2010 Aug 01.
Artículo en Inglés | MEDLINE | ID: mdl-20438752

RESUMEN

Water-soluble beta-cyclodextrin-immobilized poly(ethyleneimine) (PEICD) was synthesized by the grafting of beta-cyclodextrin to the branched poly(ethyleneimine). In an aqueous solution, this PEICD polymer could encapsulate bisphenol A, known to be a harmful compound. Additionally, the stability constant of bisphenol A to the PEICD polymer was 1.1 x 10(4)M(-1). However, the water-solubility of PEICD has been making it difficult to utilize it as an environmental material. Therefore, we prepared the DNA-PEICD composite material by mixing the double-stranded DNA and PEICD. This DNA-PEICD composite material was extremely stable in water and possessed both properties of the intercalation into the double-stranded DNA and the encapsulation into the CD cavity. As a result, this material can accumulate various harmful compounds, such as dioxin- and polychlorobiphenyl (PCB)-derivatives and bisphenol A, from a multi-component solution. Therefore, the DNA-PEICD composite material may have the potential to be used as an environmental material.


Asunto(s)
ADN/química , Contaminantes Ambientales/química , Contaminantes Ambientales/aislamiento & purificación , Polietileneimina/química , beta-Ciclodextrinas/química , Animales , Estabilidad de Medicamentos , Fosfatos/química , Soluciones , Espectrometría de Fluorescencia , Electricidad Estática , Agua/química
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA